Skip to ContentSkip to Navigation
About us Latest news News News articles

Identification and characterization of Brucella effector proteins

04 January 2012

PhD ceremony: Mr. M.F. de Jong, 16.15 uur, Aula Academiegebouw, Broerstraat 5, Groningen

Dissertation: Identification and characterization of Brucella effector proteins

Promotor(s): prof. J.M. van Dijl

Faculty: Medical Sciences

Brucellosis is a global disease of domestic and wild mammals that is caused by intracellular bacteria of the genus Brucella. Brucella species have evolved to avoid the host’s immune system and infection is usually characterized by long-term persistence of the bacteria. One important Brucella virulence factor for intracellular survival and persistence in the host is the type IV secretion system (T4SS). At the start of the work presented in this thesis it was hypothesized that Brucella would use its T4SS to translocate effector proteins into host cells, since other important bacterial pathogens of humans, such as Helicobacter pylori and Legionella pneumophila, were found to use similar systems for this purpose. The goal of this research was the identification and characterization Brucella effector proteins. This would allow us to study the host cell pathways that are manipulated by Brucella during infection in more detail. This thesis describes the identification of three Brucella proteins (VceA, VceB and VceC), that are translocated into host macrophages by the Brucella T4SS. Both VceB and VceC are targeted to the endoplasmic reticulum (ER) of cells. Further experiments identified host proteins interacting with VceB and VceC, which suggests that both these effectors could be involved in manipulation of the host immune response. In conclusion, the present studies have provided novel insights into the virulence and survival strategies of Brucella, which are needed for the development of novel therapeutic interventions.

Last modified:13 March 2020 01.01 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.